Skip to main content
Signal8

Chawla Lakhmir S

SEC insider (Form 3/4/5 filer). CIK 0001646626. Director at REVELATION BIOSCIENCES, INC. (REVB). 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 17, 2026. Located in SAN DIEGO, CA.

Companies Chawla Lakhmir S has filed insider reports for

  • REVELATION BIOSCIENCES, INC. (REVB): Director
Chawla Lakhmir S profile photo

Chawla Lakhmir S

CIK: 0001646626

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

REVELATION BIOSCIENCES, INC. logo
REVB

REVELATION BIOSCIENCES, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • REVELATION BIOSCIENCES, INC. logo
    REVB

    REVELATION BIOSCIENCES, INC.

    Aug 17, 2026
    Award
    Direct
    32K shares-
  • REVELATION BIOSCIENCES, INC. logo
    REVB

    REVELATION BIOSCIENCES, INC.

    Feb 3, 2026
    Tax Payment
    Direct
    2.3K shares at avg. $1.85$4K
  • REVELATION BIOSCIENCES, INC. logo
    REVB

    REVELATION BIOSCIENCES, INC.

    Jan 8, 2026
    Award
    Direct
    42K shares at avg. $0.90$38K
  • REVELATION BIOSCIENCES, INC. logo
    REVB

    REVELATION BIOSCIENCES, INC.

    Oct 29, 2025
    Award
    Direct
    15.6K shares at avg. $1.28$20K
  • REVELATION BIOSCIENCES, INC. logo
    REVB

    REVELATION BIOSCIENCES, INC.

    Feb 11, 2025
    Award
    Direct
    181 shares at avg. $3.87$700.47

1-5 of 5